Mytos Announces $19M Series A Funding to Automate Human Cell Manufacturing and Further Accelerate Growth

Contributed by: Business Wire

Logo

Business Wire logo

Images

Mytos Co-Founders: Ali Afshar, Ph.D (left), CEO and Ignacio Willats (right). Photo credit: Mytos
Mytos Co-Founders: Ali Afshar, Ph.D (left), CEO and Ignacio Willats (right). Photo credit: Mytos
Mytos Automated Cell Manufacturing System. Photo credit: Mytos
Mytos Automated Cell Manufacturing System. Photo credit: Mytos
Business Wire embedded0

Tags

Pharmaceutical
Research
Oncology
Software
Finance
Medical Devices
Hardware
Genetics
Data Management
Professional Services
Stem Cells
Science
Technology
Mobile/Wireless
Clinical Trials
Biotechnology
Health
Apps/Applications
Series A Funding

More Like This

Business Wire logo

Celltrio Secures $15 Million Financial Investment to Accelerate Global Expansion in Cell Culturing and Cell & Gene Therapy Automation

Business Wire logo

Automata Raises $45M Series C to Build the Operating System for AI-Ready Labs

The IRO platform

Ori Biotech Announces 10-year, $120M Partnership to Advance Automated Manufacturing for Commercial Cell Therapies

DeepCyte Raises $1.5M to Bring Single-Cell AI Toxicology to Drug Development

PR Newswire associated0

NueCell Bio Announces its Launch as a New Translational Partner for Cell Therapies with Unique Expertise to Accelerate Treatments from Discovery into GMP Manufacturing

PR Newswire associated0

Cellex Cell Professionals Surpasses 10,000 Autologous ATMP Manufacturing Batches

SG-based Startup Galatek Raises $30M Series A to Accelerate AI-powered Automation in Life Sciences and Semiconductor Manufacturing

PR Newswire associated0

Cellipont Bioservices and Adva Biotechnology Collaborate to Optimize Cell Therapy Manufacturing with the ADVA X3® Platform